Synchronous glioblastoma and medulloblastoma in a child with mismatch repair mutation

Treatment of High-Risk Neuroblastoma with Intensive Chemotherapy, Radiotherapy, Autologous Bone Marrow Transplantation, and 13-<i>cis</i>-Retinoic Acid

Katherine K. Matthay, Judith G. Villablanca, Robert C. Seeger et al. · New England Journal of Medicine · 1999 · 1.9K citations · Full text

The Molecular Basis of Turcot's Syndrome

Stanley R. Hamilton, Bo Liu, Ramon Parsons et al. · New England Journal of Medicine · 1995 · 1.1K citations · Full text

Risk-adapted craniospinal radiotherapy followed by high-dose chemotherapy and stem-cell rescue in children with newly diagnosed medulloblastoma (St Jude Medulloblastoma-96): long-term results from a prospective, multicentre trial

Amar Gajjar, Murali Chintagumpala, David M. Ashley et al. · The Lancet Oncology · 2006 · 935 citations

Neuro-oncology, Risk-adapted Craniospinal Radiotherapy, Oncology +5

Temozolomide in the treatment of high-grade gliomas in children: a report from the Children's Oncology Group

Kenneth J. Cohen, Ian F. Pollack, T. Zhou et al. · Neuro-Oncology · 2011 · 389 citations · Full text

Oncology Group, Pediatric Brain Tumors, Cancer Group +18

Genetic and clinical determinants of constitutional mismatch repair deficiency syndrome: Report from the constitutional mismatch repair deficiency consortium

Doua Bakry, Melyssa Aronson, Carol Durno et al. · European Journal of Cancer · 2014 · 229 citations

Clinical Determinants, Genetic Testing, Genetic Disorder +6